Cell and gene therapies can cure diseases once thought untreatable, yet many have struggled after approval. Usually the science isn’t the problem. The launch is: treatment centers that aren’t ready, referral pathways that lose patients, and reimbursement models built for chronic drugs. This eBook identifies and explores the ten success factors that separate CGT launches that reach patients from those that stall. It offers a practical plan for turning scientific breakthroughs into lasting patient access.
